quinoxalines has been researched along with Cardio-embolic Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, R; Li, G; Liu, S; Wang, M; Zhong, W | 1 |
1 other study(ies) available for quinoxalines and Cardio-embolic Stroke
| Article | Year |
|---|---|
Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Embolic Stroke; Fibrinolytic Agents; Male; Phosphoinositide-3 Kinase Inhibitors; Quinoxalines; Rats; Rats, Sprague-Dawley; Thiazolidinediones; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2020 |